All In MedTech

FDA Clearance Tracker · P890003-S214

MEDTRONIC CARELINK MONITOR, CARDIOSIGHT READER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 2, 2012 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 2, 2012

Approved

Time to decision

448 days

Received Feb 9, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P890003-S214
Device name
MEDTRONIC CARELINK MONITOR, CARDIOSIGHT READER
Applicant location
Mounds View, MN
Received
Feb 9, 2011
Decided
May 2, 2012
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P890003

Device type

Device class
Class III

Every decision under product code NVZ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MEDTRONIC CARELINK MONITOR MODEL 2490C, CARDIOSIGHT® READER MODEL 2020A, AND MODEL 2491 DDMA

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.